PAR4 COST-EFFECTIVENESS OF TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS AS FIRST-LINE AGENTS IN RHEUMATOID ARTHRITIS
May 1, 2004, 00:00
10.1016/S1098-3015(10)62128-6
https://www.valueinhealthjournal.com/article/S1098-3015(10)62128-6/fulltext
Title :
PAR4 COST-EFFECTIVENESS OF TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) INHIBITORS AS FIRST-LINE AGENTS IN RHEUMATOID ARTHRITIS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)62128-6&doi=10.1016/S1098-3015(10)62128-6
First page :
Section Title :
Open access? :
No
Section Order :
66